Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP522313.RAdHLGklAOqdTnEa15UYyw6X-m6ONap9bjy_XrOXt_RJ8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP522313.RAdHLGklAOqdTnEa15UYyw6X-m6ONap9bjy_XrOXt_RJ8130_assertion type Assertion NP522313.RAdHLGklAOqdTnEa15UYyw6X-m6ONap9bjy_XrOXt_RJ8130_head.
- NP522313.RAdHLGklAOqdTnEa15UYyw6X-m6ONap9bjy_XrOXt_RJ8130_assertion description "[Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP522313.RAdHLGklAOqdTnEa15UYyw6X-m6ONap9bjy_XrOXt_RJ8130_provenance.
- NP522313.RAdHLGklAOqdTnEa15UYyw6X-m6ONap9bjy_XrOXt_RJ8130_assertion evidence source_evidence_literature NP522313.RAdHLGklAOqdTnEa15UYyw6X-m6ONap9bjy_XrOXt_RJ8130_provenance.
- NP522313.RAdHLGklAOqdTnEa15UYyw6X-m6ONap9bjy_XrOXt_RJ8130_assertion SIO_000772 19074726 NP522313.RAdHLGklAOqdTnEa15UYyw6X-m6ONap9bjy_XrOXt_RJ8130_provenance.
- NP522313.RAdHLGklAOqdTnEa15UYyw6X-m6ONap9bjy_XrOXt_RJ8130_assertion wasDerivedFrom befree-20140225 NP522313.RAdHLGklAOqdTnEa15UYyw6X-m6ONap9bjy_XrOXt_RJ8130_provenance.
- NP522313.RAdHLGklAOqdTnEa15UYyw6X-m6ONap9bjy_XrOXt_RJ8130_assertion wasGeneratedBy ECO_0000203 NP522313.RAdHLGklAOqdTnEa15UYyw6X-m6ONap9bjy_XrOXt_RJ8130_provenance.